Fan Liu | Nanobiotechnology | Research Excellence Award

Ms. Fan Liu | Nanobiotechnology | Research Excellence Award

PhD | The University of Sydney | Australia

Ms. Fan Liu is an emerging researcher specializing in nanomaterials, bioimaging probes, polymer-based scaffolds, and photonic materials, with a strong interdisciplinary focus spanning nanotechnology, biomaterials, cancer diagnostics, and photocatalytic applications. Her research contributions demonstrate a consistent emphasis on designing functional nanostructures for biomedical imaging, therapeutic synergy, tissue engineering, and sustainable photoconversion systems. She has authored multiple peer-reviewed journal articles covering advanced nanosystems for cancer imaging and therapy, including tailored carbon dots for synergistic cancer treatment and nanomaterials for cancer photocatalysis therapy. Her work on dual-modal contrast agents integrating magnetic resonance and fluorescence functionalities has contributed to enhanced diagnostic precision in biomedical imaging. Additionally, she has developed a range of peptide- and polymer-based fluorescent probes with targeted imaging capabilities, enabling improved cancer detection and molecular diagnostics. A substantial part of her research portfolio focuses on 3D-printed biodegradable scaffolds utilizing poly(trimethylene carbonate), poly(ε-caprolactone), hydroxyapatite, and β-tricalcium phosphate composites for bone regeneration and multifunctional biomedical applications. These works highlight innovation in scaffold engineering, material biocompatibility, and the integration of nanomaterials into regenerative technologies. Her contributions to energy-related nanotechnology include the development of ZnS-CdSe@Co/N-C core–shell composites for visible-light CO₂ photoconversion, showcasing her interdisciplinary vision and capability in designing nanocomposites for environmental sustainability. As a corresponding author on several publications, she has demonstrated leadership in guiding research design, execution, and dissemination. Her scholarly output spans high-impact journals such as Dyes and Pigments, Materials Today Sustainability, Nanomaterials, New Journal of Chemistry, Talanta, ChemistrySelect, and Bioorganic Chemistry. Her research achievements reflect strong expertise in fluorescent probe synthesis, nanocomposite fabrication, imaging agent development, photocatalytic nanomaterials, and advanced 3D-printing strategies. She continues to contribute to the advancement of nanotechnology-driven solutions for healthcare, diagnostics, regenerative medicine, and sustainable material innovation.

Profiles: Scopus

Featured Publications

1. Liu, F., Zheng, H., & Huang, J. (2026). Tailoring carbon dots for cancer imaging and synergistic therapy. Dyes and Pigments, 246(1), 113391. https://doi.org/10.1016/j.dyepig.2025.113391

2. Ma, S. H., Jiang, L. X., Yang, W. J., Liu, F., Wang, D., Wang, F., & Huang, J. (2025). Advances of nanomaterials in cancer photocatalysis therapy. Materials Today Sustainability, 29, 101023. https://doi.org/10.1016/j.mtsust.2024.101023

3. Zheng, S.-Y., Tang, W.-Q., Zhang, M., Yan, J.-R., Liu, F., Yan, G.-P., Liang, S.-C., & Wang, Y.-F. (2022). Dual-modal polypeptide-containing contrast agents for magnetic resonance / fluorescence imaging. Bioorganic Chemistry, 129, 106161. https://doi.org/10.1016/j.bioorg.2022.106161

4. Zheng, S.-Y., Liu, Z.-W., Kang, H.-L., & Liu, F. (2022). 3D-printed scaffolds based on poly(trimethylene carbonate), poly(ε-caprolactone), and β-tricalcium phosphate. International Journal of Bioprinting, 9(1), 641.

5. Zhang, K., Xu, Y., Liu, F., Yan, G.-P., & Guo, S.-W. (2023). Preparation and properties of ZnS–CdSe@Co/N-C core/shell composites for visible light photoconversion of CO₂. New Journal of Chemistry, 47, 12550.

Sunny Kumar | Nanobiotechnology | Young Scientist Award

Mr. Sunny Kumar | Nanobiotechnology | Young Scientist Award

Researcher, CSIR-Indian Institute Of Chemical Biology, India

Mr. Sunny Kumar is an emerging researcher in cancer biology and nanomedicine, recognized for his interdisciplinary contributions that bridge molecular oncology, tumor microenvironment studies, and nanotechnology-driven therapeutics. With an h-index of 6, 11 publications, and 148 citations (as indexed in Scopus), his research reflects both productivity and impact within translational cancer science. His primary research focuses on elucidating the molecular mechanisms underlying glioma, colorectal, and breast cancer progression, emphasizing protein quality control systems such as the ubiquitin-proteasome system and their regulatory influence on oncogenic signaling. Mr. Sunny Kumar has explored novel therapeutic targets like E3 ligases (CHIP), PD-1/PD-L1 pathways, and HAUSP-MDM2 axes, offering valuable insights for cancer immunotherapy and personalized treatment strategies. In addition to mechanistic studies, Mr. Sunny Kumar integrates nanobiotechnology and drug delivery innovation, developing nanoparticle-based formulations capable of crossing the blood–brain barrier for targeted glioma therapy. His research on dual-drug nanotherapeutics and carbon nanotube-based diagnostic platforms has contributed to the advancement of precision medicine approaches for difficult-to-treat cancers. He has published extensively as first or corresponding author in high-impact journals such as Genes & Diseases (IF 9.4), BBA-Molecular Cell Research (IF 3.7), International Journal of Pharmaceutics (IF 5.2), and Journal of Medicinal Chemistry (IF 6.8). His scholarly output also includes multiple book chapters with Springer and Taylor & Francis, covering cancer proteomics, personalized therapy, and nanotherapeutics. Mr. Sunny Kumar serves as a peer reviewer for reputed journals, including BBA–Reviews on Cancer and Experimental Cell Research, further demonstrating his engagement in the scientific community. His research exhibits a robust methodological framework, integrating cell and molecular biology, bioinformatics, animal models, and nanocarrier engineering. Collectively, Mr. Sunny Kumar’s scientific endeavors underscore a commitment to next-generation cancer therapeutics, aiming to translate molecular discoveries into clinically viable nanomedicine solutions for precision oncology.

Profile: Scopus | ORCID | Google Scholar | RsearchGate

Featured Publications

1. Kumar, S., Chatterjee, M., Ghosh, P., Ganguly, K. K., Basu, M., & Ghosh, M. K. (2023). Targeting PD-1/PD-L1 in cancer immunotherapy: An effective strategy for treatment of triple-negative breast cancer (TNBC) patients. Genes & Diseases, 10(4), 1318–1350.

2. Kumar, S., Basu, M., & Ghosh, M. K. (2022). Chaperone-assisted E3 ligase CHIP: A double agent in cancer. Genes & Diseases, 9(6), 1521–1555.

3. Kumar, S., Basu, M., Ghosh, P., Ansari, A., & Ghosh, M. K. (2023). COVID‐19: Clinical status of vaccine development to date. British Journal of Clinical Pharmacology, 89(1), 114–149.

4. Kumar, S., Basu, M., Ghosh, P., Pal, U., & Ghosh, M. K. (2023). COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery. Genes & Diseases, 10(4), 1402–1428.

5. Ghosh, M. K., Kumar, S., Ganguly, K. K., Ghosh, P., Tabassum, S., Basu, B., & Basu, M. (2023). COVID-19 and cancer: Insights into their association and influence on genetic and epigenetic landscape. Epigenomics, 15(4), 227–248.

 

Assist. Prof. Dr. Israa M.S. Al-Kadmy | Nanobiotechnology Awards | Women Researcher Award

Assist. Prof. Dr. Israa M.S. Al-Kadmy | Nanobiotechnology Awards | Women Researcher Award

Assist. Prof. Dr. Israa M.S. Al-Kadmy ,Al-Mustansiriya University \ College of Science \ Department of Life Sciences , Iraq

Israa Mohammed Safa Abd Ali AL-Kadmy, born on November 30, 1984, in Baghdad, Iraq, is an accomplished researcher and academic in the fields of microbiology and nanotechnology. She earned her BSc in Biology and an MSc in Microbiology from Mustansiriyah University, Iraq. Her academic career includes positions as Assistant Lecturer, Lecturer, and Assistant Professor at various institutions, with a focus on biotechnology, molecular biology, and nanobiotechnology. She has been a Visiting Academic at Plymouth University and has taught courses at Queen’s University Belfast, Lancaster University, and Teesside University. Her research interests include molecular microbiology, nano-biotechnology, and graphene-based biosensors. Dr. AL-Kadmy is actively involved in numerous professional societies and has participated in various international conferences. She is dedicated to advancing the field of nanomaterials and their applications in health care and environmental sustainability.

Professional Profile:

Scopus

Orcid

Summary of Suitability for the Research for Women Researcher Award

Candidate: Israa Mohammed Safa Abd Ali Al-Kadmy

Israa Al-Kadmy’s dedication to advancing nanobiotechnology, her comprehensive teaching and research experience, and her active involvement in scientific communities make her an exemplary candidate for the Research for Women Researcher Award. Her work not only contributes to scientific knowledge but also has practical implications for healthcare and biosensor technologies. Her achievements in a challenging field, combined with her active engagement in both academic and charitable activities, highlight her as a leading female researcher making a meaningful impact in her domain.

🎓Education:

Israa Mohammed Safa Abd Ali AL-Kadmy completed her undergraduate studies with a Bachelor of Science in Biology from Mustansiriyah University, College of Science, Iraq, in 2006. She pursued her postgraduate education at the same institution, earning a Master of Science in Microbiology in 2012. Her MSc thesis focused on the “Detection of 16S rRNA Methylation Gene between Two Species of Gram Negative with High-Level Resistance to Aminoglycosides,” reflecting her deep engagement with molecular microbiology and resistance mechanisms

🏢Work Experience:

Israa Mohammed Safa Abd Ali AL-Kadmy has held several notable academic and research positions across prestigious institutions. She has been an Assistant Professor at Mustansiriyah University, Iraq, since May 2020. Prior to this, she served as a Lecturer at Teesside University, UK, from October 2021 to September 2022, where she taught modules on Sustainability in Chemical Engineering and Environmental and Sustainable Processing. She is currently a Lecturer in Chemical Engineering at Lancaster University, UK, starting in September 2022, where she covers Hydrogen and Fuel Cell Technologies and Chemical Process Design Project

🏆Awards and Honors:

Israa Mohammed Safa Abd Ali AL-Kadmy is an active member of several esteemed professional societies. She is affiliated with the Biological Organization Iraqis, the Science and Engineering Institute (SCIEI), and the Iraqi Society of Nanotechnology STAF ID. Her involvement extends to the International Society for Development and Sustainability (ISDS), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), and the Global Research & Development Services (GRDS). Additionally, she is a member of the European Biosafety Association (EBSA), the British Ecological Society (BES), the Microbiological Society in Europe, and the British Society for Immunology (BSI). Her participation in these organizations underscores her commitment to advancing research and development in her fields of expertise.

Publication Top Notes:

  • Sequencing Analysis and Efficient Biodiesel Production by Lipase from Pseudomonas aeruginosa“
    Citations: 1
  • “The Secrets of Environmental Pseudomonas aeruginosa in Slaughterhouses: Antibiogram Profile, Virulence, and Antibiotic Resistance Genes”
    Citations: 1
  • “The Predominance of Virulence Genes Associated with Multidrug-Resistant Serratia marcescens Isolated from Urinary Tract Infections”
  • “Reducing Environmental Pollutants of Chicken Feathers by Production and Biodegradation of the Chicken Feather Keratinase from Aspergillus niger and Its Role as the Anti-biofilm Activity”
  • “COVID-19 Associated Mucormycosis Among ICU Patients: Risk Factors, Control, and Challenges”